Acrivon Therapeutics Inc (ACRV) PT Raised at Piper Sandler on 'Positive Clinical Data'
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff raised the price target on Acrivon Therapeutics Inc (NASDAQ: ACRV) to $8.00 (from $6.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
